Does preperitoneal local anesthesia in laparoscopic gastric bypass surgery reduce postoperative pain and opioid consumption?

Does preperitoneal local anesthesia in laparoscopic gastric bypass surgery reduce postoperative pain and opioid consumption? - Preperitoneal local anesthesia in laparoscopic gastric bypass surgery.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON37220

Enrollment

Registered

2013-07-24

Start date

2014-05-21

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative pain

Interventions

Local infiltration with bupivacaine 0.5% 30-40 ml or normal saline 0.9%

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients > 18 years old - Planned laparoscopic gastric bypass surgery - Body mass index > 35

Exclusion criteria

Exclusion criteria: - No informed consent possible or obtained. - Major abdominal surgery in the past - Known side effects or allergies to morfine or bupivacaine - Use of opioids or benzodiazepines in the past 3 months - History of alcohol- or drugabuse - Indication for premedication with a benzodiazepine

Design outcomes

Primary

Measure	Time frame
- Opioid consumption - Painscores	—

Secondary

Measure	Time frame
- Side effects of opioids - Mobilisation possible within 2 hours after surgery - Length of hospitalstay - Patientsatisfaction with pain treatment	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)